JP2015531376A5 - - Google Patents

Download PDF

Info

Publication number: JP2015531376A5
Authority: JP; Japan
Prior art keywords: alkyl; ether; amine; aryl; thioether
Prior art date: 2013-09-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP2015534652A

Other languages

English (en)

Japanese (ja)

Other versions

JP6480864B2 (ja

JP2015531376A (ja

Filing date

2013-09-26

Publication date

2016-11-10

2013-09-26 Application filed filed Critical

2013-09-26 Priority claimed from PCT/US2013/061911 external-priority patent/WO2014052583A1/en

2015-11-02 Publication of JP2015531376A publication Critical patent/JP2015531376A/ja

2016-11-10 Publication of JP2015531376A5 publication Critical patent/JP2015531376A5/ja

2019-03-13 Application granted granted Critical

2019-03-13 Publication of JP6480864B2 publication Critical patent/JP6480864B2/ja

Status Active legal-status Critical Current

2033-09-26 Anticipated expiration legal-status Critical

Links

MSRNTUGCBABLOL-RTORTDFLSA-N CC(C1O)C(C(C=C2C3(C)CC[C@]4(C)C2(C)CCC(C)(CC2)C4C[C@]2(C)C(O)=O)SCCC(O)=O)=C3C=C1O Chemical compound CC(C1O)C(C(C=C2C3(C)CC[C@]4(C)C2(C)CCC(C)(CC2)C4C[C@]2(C)C(O)=O)SCCC(O)=O)=C3C=C1O MSRNTUGCBABLOL-RTORTDFLSA-N 0.000 description 1
HFQYCOVCSAAXGR-SZVMNPOISA-N CC(C1O)C(C(C=C2C3(C)CC[C@]4(C)[C@]2(C)CCC(C)(CC2)[C@H]4C[C@]2(C)C(C2)C2O)SCCN)=C3C=C1O Chemical compound CC(C1O)C(C(C=C2C3(C)CC[C@]4(C)[C@]2(C)CCC(C)(CC2)[C@H]4C[C@]2(C)C(C2)C2O)SCCN)=C3C=C1O HFQYCOVCSAAXGR-SZVMNPOISA-N 0.000 description 1
FNDCGTSZMYUGAF-FVTMPYKVSA-N CC(CCC1(C)CC2)(C[C@H]1[C@](C)(CCC13C)C2(C)C1=CC=C(C(C)=C1O)C3=CC1=O)C(O)O Chemical compound CC(CCC1(C)CC2)(C[C@H]1[C@](C)(CCC13C)C2(C)C1=CC=C(C(C)=C1O)C3=CC1=O)C(O)O FNDCGTSZMYUGAF-FVTMPYKVSA-N 0.000 description 1
WZPJRIBAQKAUTP-YYJBQZGJSA-N C[C@@](CC[C@](C)(C1)C(O)=O)(CC2)[C@@H]1[C@](C)(CCC1(C)c(c3c4C)cc(O)c4O)[C@@]2(C)C1=CC3SCCO Chemical compound C[C@@](CC[C@](C)(C1)C(O)=O)(CC2)[C@@H]1[C@](C)(CCC1(C)c(c3c4C)cc(O)c4O)[C@@]2(C)C1=CC3SCCO WZPJRIBAQKAUTP-YYJBQZGJSA-N 0.000 description 1

JP2015534652A 2012-09-27 2013-09-26 肥満の処置のための化合物およびそれの使用方法 Active JP6480864B2 (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201261706153P	2012-09-27	2012-09-27
US61/706,153		2012-09-27
PCT/US2013/061911 WO2014052583A1 (en)	2012-09-27	2013-09-26	Compounds for the treatment of obesity and methods of use thereof

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2019021437A Division JP6743211B2 (ja)	2012-09-27	2019-02-08	肥満の処置のための化合物およびそれの使用方法

Publications (3)

Publication Number	Publication Date
JP2015531376A JP2015531376A (ja)	2015-11-02
JP2015531376A5 true JP2015531376A5 (2)	2016-11-10
JP6480864B2 JP6480864B2 (ja)	2019-03-13

Family

ID=49304418

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP2015534652A Active JP6480864B2 (ja)	2012-09-27	2013-09-26	肥満の処置のための化合物およびそれの使用方法
JP2019021437A Active JP6743211B2 (ja)	2012-09-27	2019-02-08	肥満の処置のための化合物およびそれの使用方法

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2019021437A Active JP6743211B2 (ja)	2012-09-27	2019-02-08	肥満の処置のための化合物およびそれの使用方法

Country Status (21)

Country	Link
US (6)	US9968575B2 (2)
EP (3)	EP3434268B1 (2)
JP (2)	JP6480864B2 (2)
CN (3)	CN111529534A (2)
AU (3)	AU2013323528B2 (2)
BR (1)	BR112015006848A2 (2)
CA (2)	CA3030272C (2)
CY (1)	CY1121166T1 (2)
DK (1)	DK2900230T3 (2)
ES (1)	ES2696626T3 (2)
HR (1)	HRP20181879T1 (2)
HU (1)	HUE040496T2 (2)
LT (1)	LT2900230T (2)
PL (1)	PL2900230T3 (2)
PT (1)	PT2900230T (2)
RS (1)	RS58010B1 (2)
RU (2)	RU2768868C2 (2)
SI (1)	SI2900230T1 (2)
SM (1)	SMT201800604T1 (2)
TR (1)	TR201815668T4 (2)
WO (1)	WO2014052583A1 (2)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RS58010B1 (sr)	2012-09-27	2019-02-28	Childrens Medical Ct Corp	Jedinjenja za lečenje gojaznosti i postupci za njihovu upotrebu
CA3044998A1 (en) *	2014-03-26	2015-10-01	The Children's Medical Center Corporation	Celastrol and derivatives for the treatment of obesity
US20170209408A1 (en) *	2014-04-03	2017-07-27	The Children's Medical Center Corporation	Hsp90 inhibitors for the treatment of obesity and methods of use thereof
CN105985401B (zh) *	2015-02-16	2020-10-09	上海华拓医药科技发展有限公司	一种雷公藤红素衍生物、其制备方法及用途
JP7034078B2 (ja) *	2015-10-23	2022-03-11	イーアールエックスファーマシューティカルズインコーポレイテッド	セラストロールの類似体
CN106905404B (zh) *	2017-01-13	2019-08-27	广东工业大学	熊果酸衍生物及其制备方法和应用
US20250134923A1 (en) *	2021-09-09	2025-05-01	Junion Labs Pte. Ltd.	Superabsorbent hydrogels with lipase inhibitor
KR102470686B1 (ko) *	2022-06-07	2022-11-23	서울대학교산학협력단	디메틸제일아스테럴을 포함하는 대사성 질환 예방 또는 치료용 약학 조성물
CN119431489A (zh) *	2024-11-13	2025-02-14	肇源县总医院	一种雷公藤红素衍生物及其制备方法

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA791659B (en)	1978-04-17	1980-04-30	Ici Ltd	Process and apparatus for spraying liquid
GB8504253D0 (en)	1985-02-19	1985-03-20	Ici Plc	Electrostatic spraying apparatus
US4938763B1 (en)	1988-10-03	1995-07-04	Atrix Lab Inc	Biodegradable in-situ forming implants and method of producing the same
MY107937A (en)	1990-02-13	1996-06-29	Takeda Chemical Industries Ltd	Prolonged release microcapsules.
US6309853B1 (en)	1994-08-17	2001-10-30	The Rockfeller University	Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US6429290B1 (en)	1994-08-17	2002-08-06	The Rockefeller University	OB polypeptides, modified forms and derivatives
US6001968A (en)	1994-08-17	1999-12-14	The Rockefeller University	OB polypeptides, modified forms and compositions
US6350730B1 (en)	1994-08-17	2002-02-26	The Rockefeller University	OB polypeptides and modified forms as modulators of body weight
US5827734A (en)	1995-01-20	1998-10-27	University Of Washington	Materials and methods for determining ob protein in a biological sample
US5552523A (en)	1995-01-31	1996-09-03	Eli Lilly And Company	Anti-obesity proteins
US5552522A (en)	1995-01-31	1996-09-03	Eli Lilly And Company	Anti-obesity proteins
US5521283A (en)	1995-01-31	1996-05-28	Eli Lilly And Company	Anti-obesity proteins
US5532336A (en)	1995-01-31	1996-07-02	Eli Lilly And Company	Anti-obesity proteins
US5552524A (en)	1995-01-31	1996-09-03	Eli Lilly And Company	Anti-obesity proteins
AU6028396A (en)	1995-06-07	1996-12-30	Amgen, Inc.	Ob protein compositions and method
HUP9802609A2 (hu)	1995-06-30	1999-03-29	Eli Lilly And Co.	A diabetes kezelésére szolgáló eljárás
ATE259650T1 (de)	1995-08-17	2004-03-15	Amgen Inc	Verfahren zur verringerung und zur erhaltung von verringerten blutspiegeln von lipiden mittels zubereitungen von ob-proteinen
US5650167A (en) *	1995-11-16	1997-07-22	Dawa Incorporated	Method and composition for treating hepatitis B
US6936439B2 (en)	1995-11-22	2005-08-30	Amgen Inc.	OB fusion protein compositions and methods
US20030040467A1 (en)	1998-06-15	2003-02-27	Mary Ann Pelleymounter	Ig/ob fusions and uses thereof.
PT866720E (pt)	1995-11-22	2004-06-30	Amgen Inc	Proteina ob para aumentar a massa do tecido mole
AU2670897A (en)	1996-04-04	1997-10-29	Amgen, Inc.	Fibulin pharmaceutical compositions and related methods
CA2263826A1 (en)	1996-08-30	1998-03-05	Amgen Inc.	Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor
WO1998012224A1 (en)	1996-09-20	1998-03-26	Hoechst Aktiengesellschaft	Use of leptin antagonists for treating insulin resistance in type ii diabetes
PT839525E (pt)	1996-10-31	2004-10-29	Takeda Chemical Industries Ltd	Preparacao de libertacao prolongada
US5880116A (en) *	1996-12-13	1999-03-09	Neurocal International	Use of celastrol to treat alzheimer's disease
CA2275183A1 (en)	1996-12-20	1998-07-02	Amgen Inc.	Ob fusion protein compositions and methods
ATE223229T1 (de)	1997-04-17	2002-09-15	Amgen Inc	Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
WO1998055139A1 (en)	1997-06-06	1998-12-10	Smithkline Beecham Plc	Use of leptin antagonists for the treatment of diabetes
US7052678B2 (en)	1997-09-15	2006-05-30	Massachusetts Institute Of Technology	Particles for inhalation having sustained release properties
US6541033B1 (en)	1998-06-30	2003-04-01	Amgen Inc.	Thermosensitive biodegradable hydrogels for sustained delivery of leptin
JP4199421B2 (ja)	1998-08-10	2008-12-17	アムジエン・インコーポレーテツド	デキストラン−レプチン結合体、医薬組成物および関連方法
AU6396999A (en)	1998-10-02	2000-04-26	Amgen, Inc.	Method to determine a predisposition to leptin treatment
US6420339B1 (en)	1998-10-14	2002-07-16	Amgen Inc.	Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
AU781460B2 (en)	1999-02-12	2005-05-26	Amgen, Inc.	Glycosylated leptin compositions and related methods
AU2002359288B2 (en)	2001-10-22	2008-07-31	Amgen, Inc.	Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
AU2003286549B2 (en)	2002-10-21	2006-11-30	Metaproteomics, Llc	Compositions that treat or inhibit pathological conditions associated with inflammatory response
AU2003290563A1 (en)	2002-10-31	2004-05-25	Clf Medical Technology Acceleration Program, Inc.	Leptin-related peptides
RU2346688C2 (ru) *	2002-12-06	2009-02-20	Фиброген, Инк.	Регулирование содержания жира
EP1715539B1 (en)	2004-01-16	2012-11-07	Mitsubishi Materials Corporation	Separator for fuel cell, method of producing separator, and solid oxide fuel cell
US20060253100A1 (en) *	2004-10-22	2006-11-09	Medtronic, Inc.	Systems and Methods to Treat Pain Locally
CA2613041C (en)	2005-09-30	2012-03-06	Morinaga Milk Industry Co., Ltd.	Agent for improving insulin resistance
EP1948191B1 (en)	2005-11-01	2013-01-16	The Regents of the University of Michigan	Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
AU2007230991A1 (en)	2006-03-22	2007-10-04	Syndexa Pharmaceuticals Corporation	Compounds and methods for treatment of disorders associated with ER stress
US20110263693A1 (en) *	2006-03-31	2011-10-27	Dana-Farber Cancer Institute, Inc.	Celastrol, gedunin, and derivatives thereof as hsp90 inhibitors
US20080044390A1 (en)	2006-08-11	2008-02-21	Xiaowei Jin	Methods and compositions for the treatment of neurodegenerative disorders
WO2008020622A1 (en) *	2006-08-17	2008-02-21	Kyorin Pharmaceutical Co., Ltd.	NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND
EP2152252A4 (en) *	2006-11-13	2010-06-02	Univ Columbia	SELECTIVE PROTEASOMIC INHIBITORS FOR THE TREATMENT OF DIABETES
CN101279995A (zh) *	2007-04-03	2008-10-08	烟台靶点药物研究有限公司	一种雷公藤红素盐及其制备方法与用途
WO2009026163A1 (en)	2007-08-17	2009-02-26	Burnham Institute For Medical Research	Compositions and methods for inhibiting growth and metastasis of melanoma
UA97707C2 (ru) *	2007-11-14	2012-03-12	Амилин Фармасьютикалз, Инк.	Способы лечения ожирения и заболеваний, расстройств, связанных с ожирением
CN101434635B (zh)	2007-11-16	2012-05-16	上海华拓医药科技发展股份有限公司	一类具抗肿瘤活性的水溶性酚性三萜化合物及其制备方法
WO2009067245A2 (en) *	2007-11-20	2009-05-28	University Of Florida Research Foundation, Inc.	Compositions and methods for tissue repair
EP2271213A4 (en) *	2008-02-01	2011-06-29	Scripps Research Inst	METHOD FOR THE TREATMENT OF A GRADE SUFFERED BY PROTEIN HOMEOSTASIS
CN101352444A (zh) *	2008-09-11	2009-01-28	中国科学院广州生物医药与健康研究院	雷公藤红素在制药中的新应用
JP5780549B2 (ja)	2009-04-17	2015-09-16	国立大学法人広島大学	レプチン抵抗性を改善および／または予防するための薬学的組成物、並びにその使用
CN101704874A (zh) *	2009-11-26	2010-05-12	中国药科大学	五环三萜及其衍生物的二甲双胍盐、其制备方法及医药用途
DK2558105T3 (da)	2010-04-12	2020-01-27	Reata Pharmaceuticals Inc	Bardoxolonmethyl til behandling af fedme
CN101805390B (zh)	2010-04-13	2012-07-18	暨南大学	一种雷公藤红素衍生物及其用途
CN102309494A (zh) *	2010-07-01	2012-01-11	嘉兴学院	扁蒴藤素作为炎性细胞因子抑制剂的医药用途
CA2808359C (en)	2010-08-23	2019-09-24	Suzhou Neupharma Co., Ltd.	Analogs of celasterol and pharmaceutical compositions comprised thereof
EP2617726A4 (en) *	2010-09-17	2014-05-14	Takeda Pharmaceutical	DIABETES THERAPEUTIC
KR101180387B1 (ko)	2011-11-21	2012-09-10	동국대학교 산학협력단	엣지 추출을 위한 이미지 센서 및 이를 이용한 엣지 이미지 생성 방법.
JP6478908B2 (ja)	2012-05-25	2019-03-06	バーグエルエルシー	熱ショックタンパク質（ＨＳＰ）９０−βを調節することによる代謝症候群の治療方法
RS58010B1 (sr)	2012-09-27	2019-02-28	Childrens Medical Ct Corp	Jedinjenja za lečenje gojaznosti i postupci za njihovu upotrebu
CN103524592B (zh)	2013-09-27	2015-08-05	安徽医科大学	一种雷公藤红素衍生物、该衍生物的生物盐及其制备方法与用途
US9601471B2 (en)	2015-04-23	2017-03-21	Apple Inc.	Three layer stack structure

2013
- 2013-09-26 RS RS20181365A patent/RS58010B1/sr unknown
- 2013-09-26 PL PL13773562T patent/PL2900230T3/pl unknown
- 2013-09-26 RU RU2018112067A patent/RU2768868C2/ru active
- 2013-09-26 LT LTEP13773562.7T patent/LT2900230T/lt unknown
- 2013-09-26 HU HUE13773562A patent/HUE040496T2/hu unknown
- 2013-09-26 AU AU2013323528A patent/AU2013323528B2/en active Active
- 2013-09-26 EP EP18181547.3A patent/EP3434268B1/en active Active
- 2013-09-26 CN CN202010540726.XA patent/CN111529534A/zh active Pending
- 2013-09-26 TR TR2018/15668T patent/TR201815668T4/tr unknown
- 2013-09-26 SI SI201331170T patent/SI2900230T1/sl unknown
- 2013-09-26 ES ES13773562T patent/ES2696626T3/es active Active
- 2013-09-26 JP JP2015534652A patent/JP6480864B2/ja active Active
- 2013-09-26 PT PT13773562T patent/PT2900230T/pt unknown
- 2013-09-26 BR BR112015006848-0A patent/BR112015006848A2/en not_active Application Discontinuation
- 2013-09-26 CA CA3030272A patent/CA3030272C/en active Active
- 2013-09-26 SM SM20180604T patent/SMT201800604T1/it unknown
- 2013-09-26 WO PCT/US2013/061911 patent/WO2014052583A1/en not_active Ceased
- 2013-09-26 US US14/431,412 patent/US9968575B2/en active Active
- 2013-09-26 EP EP22168909.4A patent/EP4082541A1/en active Pending
- 2013-09-26 RU RU2015115696A patent/RU2650646C2/ru active
- 2013-09-26 HR HRP20181879TT patent/HRP20181879T1/hr unknown
- 2013-09-26 EP EP13773562.7A patent/EP2900230B1/en active Active
- 2013-09-26 CN CN202010540739.7A patent/CN111529535A/zh active Pending
- 2013-09-26 CA CA2886393A patent/CA2886393C/en active Active
- 2013-09-26 DK DK13773562.7T patent/DK2900230T3/en active
- 2013-09-26 CN CN201380061929.9A patent/CN104822374A/zh active Pending
2016
- 2016-10-21 AU AU2016247206A patent/AU2016247206B2/en active Active
2017
- 2017-07-07 US US15/644,247 patent/US9925161B2/en active Active
2018
- 2018-02-28 US US15/908,571 patent/US10653654B2/en active Active
- 2018-11-01 AU AU2018256619A patent/AU2018256619B2/en not_active Ceased
- 2018-11-08 CY CY20181101181T patent/CY1121166T1/el unknown
2019
- 2019-02-08 JP JP2019021437A patent/JP6743211B2/ja active Active
2020
- 2020-04-28 US US16/860,232 patent/US11045439B2/en active Active
2021
- 2021-05-21 US US17/326,944 patent/US12064408B2/en active Active
2024
- 2024-07-09 US US18/767,788 patent/US20250161252A1/en active Pending

Publication	Publication Date	Title
JP2015531376A5 (2)	2016-11-10
JP2017513824A5 (2)	2018-05-10
AU2020203101B9 (en)	2021-12-02	Tyrosine hydroxylase inhibitors for treating intestinal hyperpermeability
RU2018112067A (ru)	2019-03-07	Соединения, предназначенные для лечения ожирения, и способы их применения
RU2005123802A (ru)	2006-02-27	Производные адамантана, способы их получения и содержащие их фармацевтические композиции
KR20150013527A (ko)	2015-02-05	항염증 활성과 접합된 증진된 항인플루엔자제
JP2013534248A5 (2)	2014-10-02
RU2012128547A (ru)	2014-01-27	Дважды ацилированные производные glp-1
MY153620A (en)	2015-02-27	Novel sulphur containing lipids for use as food supplementor as medicament
RU2013137452A (ru)	2015-02-20	Композиции, содержащие расщепляемое ферментами пролекарство оксикодона
WO2009082818A8 (en)	2009-09-03	Novel c-21-keto lupane derivatives preparation and use thereof
US20210137868A1 (en)	2021-05-13	Composition and methods for treating intestinal hyperpermeability
EP2682387A3 (en)	2014-06-18	C7-fluoro substituted tetracycline compounds
JP2018502101A5 (2)	2019-01-31
RU2012145116A (ru)	2014-04-27	Фармацевтическая композиция для предупреждения или лечения неалкогольного жирового гепатоза и способ предупреждения или лечения неалкогольного жирового гепатоза с ее использованием
JP2016537431A5 (2)	2017-11-24
CA2446748A1 (en)	2002-11-21	Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
AU2007341218B2 (en)	2010-09-09	Isosorbide mononitrate derivatives for the treatment of intestinal disorders
RU2012150501A (ru)	2014-06-10	Противораковые стероидные лактоны, ненасыщенные в положении 7(8)
JP2009525265A5 (2)	2010-03-04
MX2022011242A (es)	2022-12-15	Inmunomodulación de o-het/aril azálidos.
WO2011085033A3 (en)	2011-11-17	Dp2 antagonist and uses thereof
JP2008530242A5 (2)	2009-04-16
JP2020533402A5 (2)	2021-04-15
RU2013136045A (ru)	2015-02-10	Ингибиторы каспазы-2